TRANSMEDICS GROUP INC (TMDX)
US89377M1099 - Common Stock
TRANSMEDICS GROUP INC
NASDAQ:TMDX (4/19/2024, 4:26:07 PM)
After market: 84.16 0 (0%)84.16
-3.08 (-3.53%)
Company Profile
TransMedics Group, Inc. operates as a commercial stage medical technology company. The company is headquartered in Andover, Massachusetts and currently employs 212 full-time employees. The company went IPO on 2019-05-02. The company is focused on developing organ transplant therapy for end-stage organ failure patients across multiple disease states. The company has designed and developed an organ care system (OCS), a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside of the human body. The company designed its OCS technology platform to perfuse donor organs with warm, oxygenated, nutrient-enriched blood, while maintaining the organs in a living, functioning state. The company has developed OCS products, one each for lung, heart and liver transplantation. Its products include OCS Heart, OCS Lung and OCS Liver. Its OCS product consists of three components customized for each organ, which include the OCS Console, OCS Perfusion Set and OCS Solutions. The firm is also a provider of air logistics dedicated to organ transplantation in the United States.
Company Info
TRANSMEDICS GROUP INC
200 Minuteman Road
Andover MASSACHUSETTS 01810
P: 19785520900
CEO: Waleed H. Hassanein
Employees: 212
Website: https://www.transmedics.com/
TMDX News
3 days ago - TransMedics Group, Inc.TransMedics to Report First Quarter 2024 Financial Results on April 30, 2024/PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients...
4 days ago - The Motley FoolBillionaires Are Buying These 2 Ultra-High Yield Dividend Stocks Hand Over Fist. Are They Smart Buys for Your Portfolio?Stocks that work for billionaires aren't necessarily appropriate for every investor.
7 days ago - InvestorPlaceWall Street Favorites: 3 Long-Term Stocks With Strong Buy Ratings for April 2024Wall Street analysts are rating these three long-term stocks as strong buys. Consider them for your portfolio.
7 days ago - InvestorPlace3 Must-Own Stocks for Sustained Growth Over the Next 18 MonthsPlan to buy these growth stocks since the market is significantly underpricing their potential for revenue upside over the next 18 months.
8 days ago - InvestorPlaceThe 3 Most Promising MedTech Stocks to Invest In NowMedTech stocks are often overlooked despite the inherent healthcare growth trajectory and industry-wide innovative spirit.
11 days ago - TransMedics Group, Inc.TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)/PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients...
TMDX Twits
Here you can normally see the latest stock twits on TMDX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
